Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.32 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.32 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18238710 | 0.87 | ADORA3 (0.32) | ADORA3ADORA2AADORA1 | |
| SCHEMBL18239078 | 0.73 | — | — | |
| SCHEMBL22487790 | 0.71 | ADORA1 (0.38) | ADORA3ADORA2AADORA1 | |
| SCHEMBL9178197 | 0.71 | HRH4 (0.38) | ADORA3ADORA2AADORA1 | |
| SCHEMBL12989184 | 0.69 | HRH4 (0.38) | ADORA3ADORA2AADORA1 | |
| SCHEMBL19152671 | 0.69 | SRC (0.33) | ADORA3ADORA2AADORA1 | |
| SCHEMBL19153492 | 0.63 | ADORA3 (0.32) | ADORA3ADORA2AADORA1 | |
| SCHEMBL19153784 | 0.63 | PARP1 (0.33) | — | |
| SCHEMBL23642016 | 0.63 | PDCD1 (0.40) | ADORA3ADORA2AADORA1 | |
| SCHEMBL18238834 | 0.62 | ADORA3 (0.33) | ADORA3ADORA2AADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230000993-A1 | SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME | BLINKBIO INC (US) | 2023-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230000993-A1 | SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME | CD44, MSN, AS3MT | ADORA3 4145/4885ADORA2A 4582/4885ADORA1 4484/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.